GmCAB2 Promoter for Stable Transgene Expression

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current plant transformation technologies face challenges in achieving high expression levels of multiple transgenes in specific plant tissues, leading to issues like gene silencing and reduced efficacy of transgenic products.

Innovation Solution

The development of a nucleic acid vector comprising a promoter with at least 95% sequence identity to SEQ ID NO:2, operably linked to a polylinker sequence and a non-GmCAB2 heterologous coding sequence, which drives tissue-preferred expression of transgenes in plants.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional plant transformation technologies are used to introduce multiple transgenes, then transgenic plants can be produced with desirable traits, but gene silencing occurs and transgene expression levels are reduced

Engineering Contradiction:
Improvetransgene expression stabilityVSAvoidtransgene expression level
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent utilizes the GmCAB2 promoter's specific sequence parameters and tissue-specific regulatory elements to achieve high-level transgene expression. By optimizing promoter sequence parameters and using tissue-specific transcription factor binding sites, the invention maintains stable expression without silencing while achieving high productivity in targeted tissues.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The GmCAB2 promoter drives tissue-preferred expression, creating local quality differences in gene expression. The promoter enables high-level expression specifically in certain plant tissues while maintaining stability, resolving the contradiction between expression level and stability by making expression tissue-specific rather than ubiquitous.

Inventive Principle:
Principle #3Local quality

2Adaptability or versatility

If transgenes are expressed in all plant tissues, then overall trait coverage is improved, but tissue-specific resistance and efficacy are reduced

Engineering Contradiction:
Improvetrait coverageVSAvoidtissue-specific efficacy
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The GmCAB2 promoter is tissue-specific, enabling the plant to have different expression patterns in different tissues. This allows the plant to maintain tissue-specific efficacy for particular traits while the versatility of the promoter system allows it to be used for various different transgenes, thus achieving both tissue-specific reliability and overall adaptability.

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS12319918B2Plant promoter for transgene expression
Publication Date: 2025.06.03 PIONEER HI BREED INTERNATIONAL INC
  • US12319918B2 patent drawing
  • US12319918B2 patent drawing
  • US12319918B2 patent drawing

AI summary

This disclosure concerns compositions and methods for promoting transcription of a nucleotide sequence in a plant or plant cell, employing a promoter from a GmCAB2 gene. Some embodiments relate to a promoter or a 5′ UTR from a GmCAB2 gene that functions in plants to promote transcription of operably linked nucleotide sequences. Other embodiments relate to a 3′ UTR or a terminator from a GmCAB2 gene that functions in plants to promote transcription of operably linked nucleotide sequences.